Boehringer wins FDA approval for its Pradaxa antidote with eyes on a bigger market share

Damian Garde

Ingelheim picked up an FDA nod for an injection designed to reverse the effects of its blockbuster anticoagulant , marking the first for an to a next-generation blood thinner.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS